Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
References • Levy M. Drug therapy: Pharmacologic treatment of cancer pain. NEJM 1996;335(15):1124-1132. • EPEC Project, The Robert Wood Johnson Foundation, 1999. • Storey P and Knight CF. UNIPAC 3: Assessment and Treatment of Pain in the Terminally Ill. AAHPM 2003. • Gazelle. Methadone for the treatment of pain. J Pall Med. 2003;6(4):620 • AGS Panel on Persistent Pain in Older Persons. JAGS. 2002;50:S205-S224. • American Pain Society. APS Glossary of Pain Terminology. http://www.ampainsoc.org/links/pain_glossary.htm. • Bruera E and Portenoy R. Cancer Pain Assessment and Management. Cambridge University Press, 2003. • Cherny N, Ripamonti C, Pereira J, et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Cli Oncol. 2001;19:2542-2554. • Dean M. Opioids in renal failure and dialysis patients. J Pain Symptom Manage 2004;28(5):497-504. • Gordon DB, Stevenson KK, Griffie J, et al. Opioid equianalgesic calculations. J Palliat Med. 1999;2(2):209-218. • Herr K, Bjoro K, Decker S. Tools for assessment of pain in nonverbal older adults with dementia: A state-of-the-science review. J Pain Symptom Manage 2006;31(2):170-192. • Hewitt DJ, Portenoy RK. Adjuvant drugs for neuropathic cancer pain. Topics in Palliative Care. New York: Oxford University Press 1998:31-62. • Kirsh KL, Passik SD. Palliative care of the terminally ill drug addict. Cancer Invest 2006;24:425-431. • Klaschik E, Nauck F, Ostgathe C. Constipation – modern laxative therapy. Support Care Cancer 2003;11:679-685. • McCleane G. Topical analgesics. Med Clin N Am 2007;91:125-139. • Mercadante S and Bruera E. Opioid switching: A systematic and critical review. Cancer Treatment Reviews 2006;32:304-315. • Meuser T, Pietruck C, Radbruch L, et al. Symptoms during cancer pain treatment following WHO guidelines: a longitudinal follow-up study of symptom prevalence, severity, and etiology. Pain 2001;93:247-257. • Skaer TL. Transdermal opioids for cancer pain. Health and Quality of Life Outcomes 206;4(24):1-9. • Swegle JM and Logemann C. Management of common opioid-induced adverse effects. Am Fam Physician 2006;74:1347-1354. • WHO ladder:Cancer Pain Relief and Palliative Care. Technical Report Series 804. Geneva: World Health Organization; 1990. • EPERC. End-of-life/Palliative Education Resource Center http://www.mywhatever.com/cifwriter/library/eperc/fastfact/ff_index.html • http://www.ama-cmeonline.com/pain_mgmt/module12/index.htm • Bruera E and Sweeney C. Methadone use in cancer patients with pain: A review. J Palliat Med. 2002;5(1):127-137.